Florence Lerebours
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 10, 2025
Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.
Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.
Journal: Breast cancer research : BCR
Published: November 28, 2025
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.
Journal: ESMO open
Published: November 04, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: June 18, 2025
Risk models of cancer-related cognitive complaints among early breast cancer survivors in the CANTO cohort.
Journal: Journal of the National Cancer Institute
Published: April 15, 2025
Aromatase Inhibitor-Induced Arthralgia Among Patients With Early Breast Cancer: Prevalence, Treatment Nonadherence, and Management in a Prospective Longitudinal Cohort.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 15, 2025
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Journal: The Lancet. Oncology
Published: December 05, 2024
Clinico-pathological factors predicting pathological response in early triple-negative breast cancer.
Journal: NPJ breast cancer
Published: November 06, 2024
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis.
Journal: JAMA network open
Published: August 19, 2024
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy.
Journal: Journal of translational medicine
Published: August 14, 2024
Last Updated: 09/26/2026